The present study compared the efficacy of virtual reality (VR) in virtuo exposure and in vivo exposure in the treatment of spider phobia. Two treatment conditions were compared to a waiting-list condition. A 3-month follow-up evaluation was conducted in order to assess the durability of the treatment effects. Participants were randomly assigned to the treatment groups. A total of 16 participants received the in virtuo treatment, and 16 received the in vivo treatment. The waiting-list condition included 11 participants. Participants received eight 1.5-hour treatment sessions. Efficacy was measured with the Fear of Spiders Questionnaire, the Spider Beliefs Questionnaire (SBQ-F), and a Behavioral Avoidance Test (BAT). In addition, a clinician administered the Structured Interview for DSM-IV to assess DSM-IV's criteria for specific phobia and severity. Clinical and statistically significant improvements were found for both groups. Differences in treatment groups were found on one of five measures of fear: greater improvement on the SBQ-F beliefs subscale was associated with in vivo exposure.
Supported self-care interventions are a low-intensity treatment for depression that has received little research attention in the cancer population. This is a phase II intervention only study to test the feasibility, acceptability and preliminary effectiveness of a depression self-care intervention for cancer patients who have completed their primary treatment and have moderate depressive symptoms. The self-care intervention was adapted from a successful model for people with chronic physical conditions, following focus groups with cancer care professionals and patients. The support was delivered by telephone by a trained lay coach who provided up to 8 weekly coaching contacts. A variety of recruitment methods were tested; those with the highest yield of eligible subjects per research staff time were electronic mailings to community support group members and social media posting. Sixty-eight people were contacted about the study over an 11-month period, of whom 34 (49%) were eligible; 32 were enrolled (94% recruitment rate); and 25 completed 2-month follow-up (78% retention). The mean severity of PHQ-9 depression decreased significantly from screening to 2 months (12.8 to 7.0, p < .0001). The intervention is a promising treatment option for cancer survivors, demonstrating sufficient effectiveness and feasibility to proceed with a phase III clinical trial. K E Y W O R D Scancer survivorship, depression, feasibility, intervention, self-care, self-management
The aim of this study was to assess the incremental cost-effectiveness ratios (ICERs) of two brief cognitive-behavioral therapy (CBT)Ybased interventions and a pharmacological treatment, compared with usual care, initiated in the emergency department (ED) for individuals with panic disorder (PD) with a chief complaint of noncardiac chest pain. A total of 69 patients were followed up to 6 months. The primary outcome variables were direct and indirect costs of treatment and PD severity. Panic management (PM) had an ICER of $124.05, per the Anxiety Disorders Interview Schedule for Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, severity score change (95% confidence interval [CI], $54.63Y$314.57), compared with pharmacotherapy (paroxetine), with an ICER of $213.90 (95% CI, $133.51Y$394.94), and brief CBT, with an ICER of $309.31 (95% CI, $151.27Y$548.28). The pharmacological and CBT interventions were associated with a greater clinical improvement compared with usual care at posttest. PM presented a superior ICER, suggesting that it may be a promising treatment option to implement in EDs.A total of 69 participants were included in the analysis: 54 were in one of the treatment conditions and 15 were in the usual care
Cet article porte sur une recension des écrits sur l’évaluation économique des traitements éprouvés cognitivo-comportementaux et pharmacologiques des troubles anxieux. La recherche des articles pertinents s’échelonne de 1980 à 2008, à partir des bases de données électroniques du milieu médical et psychologique. Sept études sont recensées et portent sur le trouble panique, le trouble d’anxiété généralisée, la phobie spécifique et la phobie sociale. Les traitements pharmacologiques et la psychothérapie cognitive-comportementale présentent un rapport coûts-efficacité avantageux, particulièrement lorsque comparés aux soins usuels. Les auteurs concluent que malgré le besoin de renforcer l’état des connaissances sur le rapport coûts-efficacité des interventions, il semble avantageux pour la société d’accroître l’accès aux traitements éprouvés des troubles anxieux.This article reviews the literature on economic studies of evidence-based cognitive-behavioral treatment and pharmacotherapy for anxiety disorders. Articles were identified through electronic search of medical and psychological databases between 1980 and 2008. Seven studies were identified and included panic disorder, generalized anxiety disorder, specific phobia and social phobia. Results show that evidence-based cognitive-behavior therapy and pharmacotherapy are cost-effective, usually more than usual care. Although the evidence base needs to be strengthened, it appears beneficial in increasing access to evidence-based treatments for anxiety disorders from a societal perspective.Este artículo trata de una recensión de los textos de la evaluación económica de los tratamientos cognitivo-comportamentales y farmacológicos de los trastornos de ansiedad probados. La búsqueda de los artículos pertinentes se extiende de 1980 a 2008, a partir de las bases de datos electrónicas del medio médico y psicológico. Se recensan siete estudios que tratan acerca del trastorno de pánico, el trastorno de ansiedad generalizada, la fobia específica y la fobia social. Los tratamientos farmacológicos y la psicoterapia cognitivo-comportamental presentan una relación costo-eficacidad ventajosa, particularmente al compararlos con los cuidados usuales. Los autores concluyen que a pesar de la necesidad de aumentar el estado de los conocimientos sobre la relación costo-eficacidad de las intervenciones, parece ventajoso para la sociedad incrementar el acceso a los tratamientos probados de los trastornos de ansiedad.Este artigo é uma recensão da literatura sobre a avaliação econômica dos tratamentos dos transtornos de ansiedade cognitivo-comportamentais e farmacológicos reconhecidos. A pesquisa dos artigos pertinentes se estende de 1980 a 2008, a partir dos bancos de dados eletrônicos do meio médico e psicológico. Sete estudos são recenseados e tratam sobre o transtorno do pânico, o transtorno de ansiedade generalizada, a fobia específica e a fobia social. Os tratamentos farmacológicos e a psicoterapia cognitiva-comportamental apresentam uma relação custo-eficácia vantajosa, particularmente...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.